Literature DB >> 15630959

Cytokine regulation of immunoglobulin isotype switching and expression.

R L Coffman1, H F Savelkoul, D A Lebman.   

Abstract

Several cytokines have been shown to regulate the expression of specific isotypes by affecting either the frequency of isotype switching or allowing maturation of precommited precursors. IL-4 enhances the production of IgG1 and is required for IgE production in vitro and in vivo. Evidence has been provided that Il-4 acts by enhancing switching to IgE, and perhaps IgG1. IFN-gamma was shown to stimulate the secretion of IgG2a in concentrations at which it inhibits IL-4 induced production of IgG1 and IgE. IL-5, on the other hand, appears to stimulate maturation. Recent evidence suggests that transforming growth factor-beta induces switching to IgA, despite the inhibitory activity on other isotypes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 15630959

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  18 in total

Review 1.  Activating and inhibitory FcgammaRs in autoimmune disorders.

Authors:  Falk Nimmerjahn
Journal:  Springer Semin Immunopathol       Date:  2006-10-01

2.  Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity.

Authors:  William C Weldon; Maria P Martin; Vladimir Zarnitsyn; Baozhong Wang; Dimitrios Koutsonanos; Ioanna Skountzou; Mark R Prausnitz; Richard W Compans
Journal:  Clin Vaccine Immunol       Date:  2011-02-02

Review 3.  CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes.

Authors:  A Bhushan; L R Covey
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch.

Authors:  Anahit Ghochikyan; Mikayel Mkrtichyan; Irina Petrushina; Nina Movsesyan; Adrine Karapetyan; David H Cribbs; Michael G Agadjanyan
Journal:  Vaccine       Date:  2005-12-05       Impact factor: 3.641

5.  A generally applicable translational strategy identifies S100A4 as a candidate gene in allergy.

Authors:  Sören Bruhn; Yu Fang; Fredrik Barrenäs; Mika Gustafsson; Huan Zhang; Aelita Konstantinell; Andrea Krönke; Birte Sönnichsen; Anne Bresnick; Natalya Dulyaninova; Hui Wang; Yelin Zhao; Jörg Klingelhöfer; Noona Ambartsumian; Mette K Beck; Colm Nestor; Elsa Bona; Zou Xiang; Mikael Benson
Journal:  Sci Transl Med       Date:  2014-01-08       Impact factor: 17.956

6.  Meteorin-like/Meteorin-β Is a Novel Immunoregulatory Cytokine Associated with Inflammation.

Authors:  Irina Ushach; Gerardo Arrevillaga-Boni; Gina N Heller; Egest Pone; Marcela Hernandez-Ruiz; Jovani Catalan-Dibene; Peter Hevezi; Albert Zlotnik
Journal:  J Immunol       Date:  2018-11-21       Impact factor: 5.422

7.  Structure and expression of germ line immunoglobulin heavy-chain epsilon transcripts: interleukin-4 plus lipopolysaccharide-directed switching to C epsilon.

Authors:  P Rothman; Y Y Chen; S Lutzker; S C Li; V Stewart; R Coffman; F W Alt
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

8.  The tick salivary protein, Salp15, inhibits the development of experimental asthma.

Authors:  Sara A Paveglio; Jenna Allard; Jana Mayette; Laurie A Whittaker; Ignacio Juncadella; Juan Anguita; Matthew E Poynter
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

9.  Inhalation of ortho-phthalaldehyde vapor causes respiratory sensitization in mice.

Authors:  Victor J Johnson; Jeffrey S Reynolds; Wei Wang; Kara Fluharty; Berran Yucesoy
Journal:  J Allergy (Cairo)       Date:  2011-07-14

10.  Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine.

Authors:  William C Weldon; Vladimir G Zarnitsyn; E Stein Esser; Misha T Taherbhai; Dimitrios G Koutsonanos; Elena V Vassilieva; Ioanna Skountzou; Mark R Prausnitz; Richard W Compans
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.